This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lainchbury, J. G. Articles by Richards, A. M. Search for Related Content PubMed PubMed Citation Articles by Lainchbury, J. G. Articles by Richards, A. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Other heart failure Cardiovascular Pharmacology

(Hypertension. 1999;34:70-75.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Bioactivity and Interactions of Adrenomedullin and Brain Natriuretic Peptide in Patients With Heart Failure

John G. Lainchbury; M. Gary Nicholls; Eric A. Espiner; Timothy G. Yandle; Lynley K. Lewis; A. Mark Richards

From the Department of Medicine, Christchurch Hospital, Christchurch, New Zealand.

Correspondence to Professor M.G. Nicholls and Professor A. Mark Richards, Department of Medicine, Christchurch Hospital, Riccarton Ave, PO Box 4345, Christchurch, New Zealand. E-mail bgriffin{at}chmeds.ac.nz

Abstract—Plasma concentrations of the recently discovered hormones adrenomedullin (ADM), from vascular tissue, and brain natriuretic peptide (BNP), secreted by myocardium, are elevated in patients with heart failure. We tested the hypotheses that short-term increments in circulating levels of these hormones, within the pathophysiological range, would have biological effects and that the 2 hormone systems interact. Eight patients with heart failure (left ventricular ejection fractions <35%) received 4-hour infusions of BNP (3.0 pmol · kg^-1 · min^-1) alone, ADM (2.7 pmol · kg^-1 · min^-1 and 5.4 pmol · kg^-1 · min^-1 for 2 hours each) alone, ADM and BNP combined, and placebo. BNP and ADM infusions raised plasma levels of the respective peptide within the pathophysiological range. Arterial blood pressure fell (P<0.05) with all peptide infusions, but cardiac output was unchanged. Heart rate increased with ADM and combined infusions (P<0.01). Sodium excretion rose (P<0.05), and creatinine clearance was sustained during both BNP and combined infusions. Urine volume increased in response to BNP alone (P=0.02). Despite a >2-fold increase in plasma renin with both ADM and combined infusions (P<0.05), plasma aldosterone remained lower than time-matched placebo levels. Plasma noradrenaline was increased by combined, BNP, and higher dose ADM infusions (P<0.05). ADM suppressed plasma cGMP (P<0.05) and inhibited the plasma cGMP response to BNP (P<0.05). The vascular hormones ADM and BNP, produced by myocardium, at plasma concentrations within the pathophysiological range have hemodynamic, renal, and hormonal effects and measurable interactions in patients with heart failure.

Key Words: heart failure • adrenomedullin • natriuretic peptides • arterial pressure

This article has been cited by other articles:

				T. Nishikimi, F. Yoshihara, S. Horinaka, N. Kobayashi, Y. Mori, K. Tadokoro, K. Akimoto, N. Minamino, K. Kangawa, and H. Matsuoka Chronic Administration of Adrenomedullin Attenuates Transition From Left Ventricular Hypertrophy to Heart Failure in Rats Hypertension, November 1, 2003; 42(5): 1034 - 1041. [Abstract] [Full Text] [PDF]

				T. Nishikimi, K. Tadokoro, Y. Mori, X. Wang, K. Akimoto, F. Yoshihara, N. Minamino, K. Kangawa, and H. Matsuoka Ventricular Adrenomedullin System in the Transition From LVH to Heart Failure in Rats Hypertension, March 1, 2003; 41(3): 512 - 518. [Abstract] [Full Text] [PDF]

				M. T. Rademaker, C. J. Charles, E. A. Espiner, M. G. Nicholls, and A. M. Richards Long-Term Adrenomedullin Administration in Experimental Heart Failure Hypertension, November 1, 2002; 40(5): 667 - 672. [Abstract] [Full Text] [PDF]

				M. T. Rademaker, C. J. Charles, G. J.S. Cooper, D. H. Coy, E. A. Espiner, L. K. Lewis, M. G. Nicholls, and A. M. Richards Combined Endopeptidase Inhibition and Adrenomedullin in Sheep With Experimental Heart Failure Hypertension, January 1, 2002; 39(1): 93 - 98. [Abstract] [Full Text] [PDF]

				C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF]

				P. VIJAY Adrenomedullin in the treatment of pulmonary hypertension Heart, December 1, 2000; 84(6): 575 - 576. [Full Text]